Skip to main content
TrendingNews.today
World News
S&P 500 5,142.30 ▲ +0.87%|NASDAQ 16,284.75 ▲ +1.12%|DOW 38,972.10 ▼ -0.23%|AAPL $192.45 ▲ +1.80%|TSLA $241.80 ▼ -2.10%|AMZN $178.92 ▲ +0.54%|GOOGL $141.20 ▲ +0.32%|MSFT $415.60 ▼ -0.15%|
S&P 500 5,142.30 ▲ +0.87%|NASDAQ 16,284.75 ▲ +1.12%|DOW 38,972.10 ▼ -0.23%|AAPL $192.45 ▲ +1.80%|TSLA $241.80 ▼ -2.10%|AMZN $178.92 ▲ +0.54%|GOOGL $141.20 ▲ +0.32%|MSFT $415.60 ▼ -0.15%|
As of Mar 25
ScienceUnited States1 sourcesNeutral

China’s pharma rise rattles US policymakers

U.S. lawmakers and industry experts are raising alarm over China’s expanding dominance across the pharmaceutical supply chain, warning that reliance on Chinese inputs poses a growing national security and public health risk.

TS
tamra sami
via Bioworld
ShareRead original

Read the full article at Bioworld →

China’s pharma rise rattles US policymakers

Source Verification

Corroboration Score: 1

This story was independently reported by 1 sources. Click any source to read the original article.

Bioworld
Bioworld
NewsDataUS

Comments

0 comments
Be respectful and constructive.
Loading comments...
Previous
What time is Senate vote today on shutdown 2026? Next vote, DHS news
Next
Iran War: Is the New Zealand economy cooked?

Related Articles

This pinot noir hasn’t changed in 500 yearsScience
This pinot noir hasn’t changed in 500 years
Popular Science-13h ago-1 sources
Gilead pens dual-purpose $2B Ouro M&A deal with GalapagosScience
Gilead pens dual-purpose $2B Ouro M&A deal with Galapagos
Bioworld-13h ago-1 sources
Karyopharm phase III Sentry entry bucks rux in MF; to FDA nextScience
Karyopharm phase III Sentry entry bucks rux in MF; to FDA next
Bioworld-13h ago-1 sources